STOCK TITAN
  1. Home
  2. Sec-filings
  3. SXTC
  4. [EFFECT] China SXT Pharmaceuticals, Inc. SEC Filing

[EFFECT] China SXT Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 14, 2025
Accession Number: 0001213900-25-108213
Submission Type: POS AM
CIK: 0001723980
Company Name: China SXT Pharmaceuticals, Inc.
File Number: 333-282776

Source: View Original Filing on SEC EDGAR

Stock SXTC logo
China Sxt Pharmaceuticals Inc

NASDAQ:SXTC

SXTC Rankings

#6259 Ranked by Market Cap
N/A Ranked by Dividends

SXTC Latest News

Jan 15, 2026
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
Jan 9, 2026
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
Jan 8, 2026
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT
Mar 17, 2025
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency
Feb 21, 2025
China SXT Pharmaceuticals, Inc. Announces Share Consolidation

SXTC Latest SEC Filings

Jan 13, 2026
[6-K] China SXT Pharmaceuticals, Inc. Current Report (Foreign Issuer)
Jan 12, 2026
[424B5] China SXT Pharmaceuticals, Inc. Prospectus Supplement (Debt Securities)
Nov 10, 2025
[F-3] China SXT Pharmaceuticals, Inc. Foreign Issuer Shelf Registration
Nov 10, 2025
[POS AM] China SXT Pharmaceuticals, Inc. SEC Filing
Aug 7, 2025
[SCHEDULE 13G] China SXT Pharmaceuticals, Inc. SEC Filing

SXTC Stock Data

12.16M
87.04M
35.33%
0.07%
0.04%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
China
Taizhou